Health Care & Hospital Law,
Civil Litigation
Aug. 26, 2021
6 states not yet in national opioid settlement
The proposed deal, so far approved by 44 states, would provide $26 billion to be distributed among thousands of communities over several years.
Six states have not fully signed onto a proposed $26 billion nationwide settlement with Johnson & Johnson and three drug distributors accused of fueling the nation's opioid crisis. But it's not clear if the deal will be extinguished by the holdouts, who say they may do better going to court.
Joseph F. Rice of Motley Rice LLP, along with members of the Plaintiffs' Executive Committee negotiating the settlement terms on behalf of 3,000 co...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Civil Litigation
Challenge to pharmacy’s opioid control is dismissed
By Winston Cho
Health Care & Hospital Law, Civil Litigation
Some plaintiffs are asking if $26B opioid settlement is enough
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Plaintiffs urge all states to agree to $26B opioid deal, California case nears end
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
State’s opioid trial goes on, seeks twice the amount of global settlement
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
No link between J&J opioids and sales in California, expert testifies
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
California joins opponents of $4.5B Purdue Pharma settlement
By Craig Anderson
Health Care & Hospital Law, Civil Litigation
Former J&J medical consultant testifies in OC opioid trial
By Blaise Scemama
